Aldeyra Therapeutics Inc. buy marge
Start price
28.09.18
/
50%
€12.09
Target price
30.07.19
€17.14
Performance (%)
-58.96%
End price
30.07.19
€4.96
Summary
This prediction ended on 30.07.19 with a price of €4.96. Massive losses of -58.96% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aldeyra Therapeutics Inc. | -56.773% | -56.773% | -73.991% | -76.759% |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
Comments by marge for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von stratec zu
marge stimmt am 28.09.2018 der Buy-Einschätzung von stratec mit dem Kursziel 19$ zu.
Überschrift: Aldeyra multiple trials are set to read out in the second half of the year
(Vom Mitglied beendet)